n(g),n(g')-dimethyl-l-arginine has been researched along with Glucose Intolerance in 5 studies
N,N-dimethylarginine: asymmetric dimethylarginine; do not confuse with N,N'-dimethylarginine
Glucose Intolerance: A pathological state in which BLOOD GLUCOSE level is less than approximately 140 mg/100 ml of PLASMA at fasting, and above approximately 200 mg/100 ml plasma at 30-, 60-, or 90-minute during a GLUCOSE TOLERANCE TEST. This condition is seen frequently in DIABETES MELLITUS, but also occurs with other diseases and MALNUTRITION.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Asymmetric dimethylarginine (ADMA), an endogenous inhibitor of nitric oxide synthase, is a biomarker and mediator of cardiovascular disease in patients with impaired glucose tolerance (IGT) or diabetes mellitus (DM)." | 9.17 | Pioglitazone decreases asymmetric dimethylarginine levels in patients with impaired glucose tolerance or type 2 diabetes. ( Imaizumi, T; Mizoguchi, M; Tahara, A; Tahara, N; Yamagishi, S, 2013) |
| "Asymmetric dimethylarginine (ADMA), an endogenous inhibitor of nitric oxide synthase, is a biomarker and mediator of cardiovascular disease in patients with impaired glucose tolerance (IGT) or diabetes mellitus (DM)." | 5.17 | Pioglitazone decreases asymmetric dimethylarginine levels in patients with impaired glucose tolerance or type 2 diabetes. ( Imaizumi, T; Mizoguchi, M; Tahara, A; Tahara, N; Yamagishi, S, 2013) |
| "We aimed to evaluate plasma asymmetric dimethylarginine (ADMA) concentrations and its relation with insulin sensitivity/resistance indices in pregnant women with different degrees of carbohydrate intolerance." | 3.77 | Asymmetric dimethylarginine level in hyperglycemic gestation. ( Kafkasli, A; Karabulut, AB; Sertkaya, AC; Turkcuoglu, I, 2011) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 5 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Tahara, N | 2 |
| Kojima, R | 1 |
| Yoshida, R | 1 |
| Bekki, M | 1 |
| Sugiyama, Y | 1 |
| Tahara, A | 2 |
| Maeda, S | 1 |
| Honda, A | 1 |
| Igata, S | 1 |
| Nakamura, T | 1 |
| Sun, J | 1 |
| Matsui, T | 2 |
| Fukumoto, Y | 1 |
| Yamagishi, SI | 1 |
| Surdacki, A | 1 |
| Kruszelnicka, O | 1 |
| Rakowski, T | 1 |
| Jaźwińska-Kozuba, A | 1 |
| Dubiel, JS | 1 |
| Yamagishi, S | 1 |
| Mizoguchi, M | 1 |
| Imaizumi, T | 1 |
| Huang, S | 1 |
| Zou, D | 1 |
| Peng, W | 1 |
| Jiang, X | 1 |
| Shao, K | 1 |
| Xia, L | 1 |
| Tang, Y | 1 |
| Sertkaya, AC | 1 |
| Kafkasli, A | 1 |
| Turkcuoglu, I | 1 |
| Karabulut, AB | 1 |
2 trials available for n(g),n(g')-dimethyl-l-arginine and Glucose Intolerance
| Article | Year |
|---|---|
Serum Levels of Protein-Bound Methylglyoxal-Derived Hydroimidazolone-1 are Independently Correlated with Asymmetric Dimethylarginine.
Topics: Aged; Arginine; Cross-Sectional Studies; Diabetes Mellitus, Type 2; Female; Glucose Intolerance; Gly | 2019 |
Pioglitazone decreases asymmetric dimethylarginine levels in patients with impaired glucose tolerance or type 2 diabetes.
Topics: Aged; Aged, 80 and over; Arginine; Diabetes Mellitus, Type 2; Female; Fibronectins; Glucose Intolera | 2013 |
3 other studies available for n(g),n(g')-dimethyl-l-arginine and Glucose Intolerance
| Article | Year |
|---|---|
Asymmetric dimethylarginine predicts decline of glucose tolerance in men with stable coronary artery disease: a 4.5-year follow-up study.
Topics: Adult; Aged; Angina, Stable; Arginine; Diabetes Mellitus, Type 2; Follow-Up Studies; Glucose Intoler | 2013 |
The prediction roles of asymmetric dimethyl-arginine, adiponectin and apelin for macroangiopathy in patients with impaired glucose regulation.
Topics: Adiponectin; Aged; Apelin; Arginine; Atherosclerosis; Blood Glucose; Coronary Disease; Female; Gluco | 2016 |
Asymmetric dimethylarginine level in hyperglycemic gestation.
Topics: Adult; Arginine; Blood Glucose; Body Mass Index; Case-Control Studies; Chromatography, High Pressure | 2011 |